Work

Insulin and C-peptide response patterns in newly diagnosed Type 2 diabetes patients versus healthy controls: Demographic, anthropometric, and metabolic correlates

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Objective: To compare insulin and C-peptide levels between patients with newly-diagnosed Type 2 diabetes mellitus (T2DM) and non-DM controls, and to assess relationships between insulin, C-peptide and blood pressure, body mass index (BMI) and the homeostatic model assessment (HOMA) of insulin resistance (HOMA-IR) and beta cell function (HOMA-β). Results: A case-control study of 100 newly-diagnosed, T2DM patients and 100 controls. Variables studied were fasting and 2-hour post-prandial (2HPP) glucose, insulin, C-peptide, HOMA-IR and HOMA-β. Compared to controls, cases had higher median BMI ( P < 0.001) and blood pressure ( P < 0.001), but lower plasma fasting insulin (FPI, 2.96 vs 10.87 µIU/ml; P = 0.001), 2HPP insulin (7.42 vs 13.21 µIU/Ml; P < 0.001), fasting C-peptide (0.17 vs 0.32 ng/ml; P < 0.001) and 2HPP C-peptide (0.60 vs 1.10 ng/ml; P < 0.001). Median FPI in cases was higher in men and correlated with HOMA-IR (Spearman ρ = 0.45; P < 0.001) and HOMA-β (Spearman ρ = 0.46; P < 0.001), but C-peptide didn’t differ by gender, BMI or glycemic control. These findings show newly diagnosed T2DM patients in the study area had depleted β-cell function. Early assessment of β-cell reserve among Nigerians with T2DM could guide early insulin therapy.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7234961935
Cites: 28
Cited by:
Related to: 10